Skip to Main content Skip to Navigation
Journal articles

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

O. Tredan 1 C. Menetrier-Caux 2 Isabelle Ray-Coquard 1 G. Garin C. Cropet E. Verronese Thomas Bachelot 1 P. Rebattu E. Heudel 1 Pierre Cassier Sylvie Chabaud T. Croughs Pierre Dupont C. Cadore G. Clapisson A. Delgado 3 C. Bardin-Dit-Courageot C. Rigal A. N'Kodia L. Gilles-Afchain M. Morre David Perol 1 J.y. Blay 1 Christophe Caux 4 
1 Centre Léon Bérard [Lyon]
2 Equipe 11
Centre Léon Bérard [Lyon]
3 Universidad de Alicante
4 UNICANCER/CRCL - Centre de Recherche en Cancérologie de Lyon
Keywords : Breast Patients
Document type :
Journal articles
Complete list of metadata
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01795705
Contributor : Lauriane Pillet Connect in order to contact the contributor
Submitted on : Friday, May 18, 2018 - 4:38:39 PM
Last modification on : Wednesday, November 3, 2021 - 4:35:08 AM

Links full text

openaccess

Identifiers

Collections

CNRS | UNIV-LYON1 | CRCL | UDL

Citation

O. Tredan, C. Menetrier-Caux, Isabelle Ray-Coquard, G. Garin, C. Cropet, et al.. ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients. Annals of Oncology, Elsevier, 2017, ⟨10.1093/annonc/mdx058⟩. ⟨hal-01795705⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

34